News | December 09, 2024
AbbVie announces emotional impact report on mental health of underrepresented CLL cancer patients
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
The celebrations began with the unveiling of the Biocon Anthem
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of mortality
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
_256_384.jpg)
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
Subscribe To Our Newsletter & Stay Updated
